PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17372087-0	2007	The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer.	Etoposide	78-87	CD44 molecule (Indian blood group)	Homo sapiens	28-32	
21935404-11	2011	Our results thus reveal that 1) not all DTCs are necessarily CSCs; 2) conventional chemotherapeutic drugs such as taxol and etoposide may directly target CD44(+) tumor-initiating cells; and 3) DTCs generated via chronic drug selection involve epigenetic mechanisms.	Etoposide	124-133	CD44 molecule (Indian blood group)	Homo sapiens	154-158	
27009862-0	2016	Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells.	Etoposide	42-51	CD44 molecule (Indian blood group)	Homo sapiens	55-59	
27009862-4	2016	Drugs that performed best in docking were examined in molecular dynamics simulations, identifying etoposide as a potential CD44 antagonist.	Etoposide	98-107	CD44 molecule (Indian blood group)	Homo sapiens	123-127	
27009862-8	2016	Moreover, etoposide decreased the proportion of CD44+/CD24- cells, lowered chemoresistance, and blocked mammosphere formation.	Etoposide	10-19	CD44 molecule (Indian blood group)	Homo sapiens	48-52	
27009862-9	2016	Our data indicate that etoposide blocks CD44 activation, impairing key cellular functions that drive malignancy, thus rendering it a candidate for further translational studies and a potential lead compound in the development of new CD44 antagonists.	Etoposide	23-32	CD44 molecule (Indian blood group)	Homo sapiens	40-44	
27009862-9	2016	Our data indicate that etoposide blocks CD44 activation, impairing key cellular functions that drive malignancy, thus rendering it a candidate for further translational studies and a potential lead compound in the development of new CD44 antagonists.	Etoposide	23-32	CD44 molecule (Indian blood group)	Homo sapiens	233-237	
12297287-4	2002	Cells expressing CD44 were significantly resistant to etoposide-induced apoptosis.	Etoposide	54-63	CD44 molecule (Indian blood group)	Homo sapiens	17-21	
15215046-5	2004	Mock-transfected and CD44-transfected cells were exposed to etoposide to induce apoptosis.	Etoposide	60-69	CD44 molecule (Indian blood group)	Homo sapiens	21-25	
15215046-7	2004	It was observed that resistance to apoptosis induced by etoposide is promoted by CD44 expression in SW620, and this resistance is better sustained by the full variant isoform, v3-10.	Etoposide	56-65	CD44 molecule (Indian blood group)	Homo sapiens	81-85	
10910943-3	2000	Using 2 myeloid cell lines, HL60 and NB4, evidence is presented that prior incubation with the CD44-specific monoclonal antibody (mAb) A3D8, reported to induce differentiation of AML blasts, significantly decreases apoptosis induced by 3 drugs used in AML chemotherapy: daunorubicin (DNR), mitoxantrone, and etoposide.	Etoposide	308-317	CD44 molecule (Indian blood group)	Homo sapiens	95-99